Supplementary Materials and Methods from High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells

Authors :: M. Emmy M. Dolman
Jan J. Molenaar
Kelly C. Goldsmith
Jan Koster
Ronald W. Stam
Mark Kerstjens
David A. Egan
Daphne Lelieveld
Linda Schild
Nil A. Schubert
Hunter C. Jonus
Bianca Koopmans
Jasmine Y. Lee
Lindy K. Alles
Laurel T. Bate-Eya
Lindy Vernooij
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary information on the used materials and methods.

Tools